Troy Wilson

Troy Wilson

Directeur/Membre du Conseil chez PUMA BIOTECHNOLOGY, INC.

Fortune : 16 M $ au 31/08/2026

57 ans
Health Technology
Commercial Services
Consumer Services

Profil

Troy E.
Wilson
was the founder of Ambrx, Inc. founded in 2003, serving as Chief Business Officer.
Dr. Wilson was the founder of Intellikine LLC founded in 2007, serving as President, Chief Executive Officer & Director from 2007 to 2012.
Dr. Wilson was the founder of Avidity Biosciences, Inc. founded in 2012, serving as Non-Executive Chairman from 2021 to 2026.
Dr. Wilson was the founder of Araxes Pharma LLC founded in 2012, serving as President, CEO, Director & Managing Member from 2012 to 2019.
Dr. Wilson was the founder of Kura Oncology, Inc. founded in 2014, serving as Chairman, President, Chief Executive Officer & CFO from 2022 to 2026.
Dr. Wilson is also the founder of Wildcat Discovery Technologies, Inc...
Dr. Wilson is Executive Chairman at Abintus Bio, Inc. since 2020.
Dr. Wilson is Independent Director at Puma Biotechnology, Inc. since 2013.
Dr. Wilson is Director at Atrium Therapeutics, Inc. starting 2026.
Dr. Wilson is Director at Cipher Genetics, Inc. Dr. Wilson is Director at Cartography Biosciences, Inc. Dr. Wilson is Director at Montara Therapeutics, Inc. Dr. Wilson was Chairman, President & Chief Executive Officer at Zeta Acquisition Corp.
III.
Dr. Wilson was Chief Executive Officer at Takeda Pharmaceuticals U.S.A., Inc. Dr. Wilson was Executive Chairman at Wellspring Biosciences LLC from 2019 to 2023.
Dr. Wilson was Director at ZP Opco, Inc. Dr. Wilson was Independent Director at Zosano Pharma Corp.
from 2014 to 2019.
Dr. Wilson was Founding Partner at Presidio Partners.
Dr. Wilson was Vice President-Business Development at Novartis Institute for Functional Genomics, Inc. Dr. Wilson completed graduate education at New York University.
Dr. Wilson completed undergraduate and doctorate education at the University of California, Berkeley.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
24/08/2026 1 214 650 ( 1,37% ) 15 M $ 31/08/2026
14/09/2026 55 300 ( 0,11% ) 503 783 $ 31/08/2026
-.--%
27/02/2026 0 ( -.--% ) - $ 31/08/2026

Postes actifs de Troy Wilson

SociétésPosteDébut
PUMA BIOTECHNOLOGY, INC. Directeur/Membre du Conseil 18/10/2013
Directeur/Membre du Conseil -
Président 01/10/2020
Directeur/Membre du Conseil -

Anciens postes connus de Troy Wilson

SociétésPosteFin
KURA ONCOLOGY, INC. Directeur Général 10/09/2026
AVIDITY BIOSCIENCES, INC. Directeur Général 01/02/2019
Directeur Général 01/02/2019
ZOSANO PHARMA CORPORATION Directeur/Membre du Conseil 05/10/2019
Fondateur 01/01/2012
Voir l'expérience en détail de Troy Wilson

Formation de Troy Wilson

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

58

Relations au 1er degré

19

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées19

Health Technology

Commercial Services

Miscellaneous

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Finance

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Commercial Services

Health Technology

  1. Bourse
  2. Insiders
  3. Troy Wilson